# FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2024 · $512,266

## Abstract

The objectives of this study are to determine target organ toxicity and toxicokinetic (TK) parameters of NCGC72 and its reversibility.

## Key facts

- **NIH application ID:** 11219849
- **Project number:** 75N95024D00020-0-759502400002-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** THOMAS HORN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $512,266
- **Award type:** —
- **Project period:** 2024-09-18 → 2025-02-10

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11219849

## Citation

> US National Institutes of Health, RePORTER application 11219849, FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS (75N95024D00020-0-759502400002-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11219849. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*